Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 07/28 07:57:20 am
44.965 EUR   -0.76%
07/27MORPHOSYS : Commerzbank Downgrades MorphoSys to Hold Rating From Buy
MT
07/26EUROPE : European stocks ease from peaks, Prosus hits 1-year low
RE
07/26European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PRESS RELEASE : MorphoSys Commences Cash Tender -2-

06/16/2021 | 05:46pm EDT
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      MorphoSys AG 
              Semmelweisstr. 7 
              82152 Planegg 
              Germany 
Phone:        +49 (0)89 899 27-0 
Fax:          +49 (0)89 899 27-222 
E-mail:       investors@morphosys.com 
Internet:     www.morphosys.com 
ISIN:         DE0006632003 
WKN:          663200 
Indices:      MDAX, TecDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Nasdaq 
EQS News ID:  1208676 
 
End of News   DGAP News Service 
=------------ 

1208676 2021-06-16

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1208676&application_name=news 
 

(END) Dow Jones Newswires

June 16, 2021 17:44 ET (21:44 GMT)

All news about MORPHOSYS AG
07/27MORPHOSYS : Commerzbank Downgrades MorphoSys to Hold Rating From Buy
MT
07/26EUROPE : European stocks ease from peaks, Prosus hits 1-year low
RE
07/26European ADRs Move Higher in Monday Trading
MT
07/26AD HOC : MorphoSys AG to update financial guidance for 2021 and reduce financial..
PU
07/26SECTOR UPDATE : Health Care Stocks Retreat Premarket Monday
MT
07/26MORPHOSYS : Revises Group Revenue Guidance, Sees Higher Group Operating Expenses..
MT
07/26AD-HOC : MorphoSys AG to update financial guidance for 2021 and reduce financial..
PU
07/26DGAP-ADHOC : Ad-hoc: MorphoSys AG to update financial guidance for 2021 and redu..
DJ
07/26MorphoSys AG Revises Financial Guidance for 2021
CI
07/26European stocks ease from peaks, Prosus hits 1-year low
RE
More news
Financials
Sales 2021 170 M 201 M 201 M
Net income 2021 -239 M -283 M -283 M
Net cash 2021 601 M 710 M 710 M
P/E ratio 2021 -7,00x
Yield 2021 -
Capitalization 1 545 M 1 828 M 1 826 M
EV / Sales 2021 5,56x
EV / Sales 2022 3,55x
Nbr of Employees 609
Free-Float 99,6%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 45,31 €
Average target price 105,07 €
Spread / Average Target 132%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Malte Peters Chief Research & Development Officer
Roland Wandeler Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-51.71%1 828
MODERNA, INC.214.44%131 902
LONZA GROUP AG20.01%55 520
IQVIA HOLDINGS INC.35.73%46 608
CELLTRION, INC.-26.60%31 131
SEAGEN INC.-17.54%26 209